% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • michaelroman910 michaelroman910 Dec 21, 2012 8:29 AM Flag

    Barron's " LAZARD CAPITAL Says Commerical Opportunity for SRPT $83 to $139 A Share" LINK

    Barron's Updated 11/21/12 By: Andrew Bary
    Lazard Capital Markets analyst William Tanner said" The US commercial opportunity for Sarepta with eteplirsen implied a stock price of $83 to $139 a share. "

33.62+1.70(+5.33%)2:34 PMEDT